DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/gfrvn4/investing_in) has announced the addition of the "Investing in Global Medical Device Sector: Risk Analysis and Management 2014-2020" report to their offering.
The global medical devices (MD) market represents a steady growing industrial sector as well as an attractive investment opportunity for profitable rewards. However, the potential for greater investment return may be constrained by a number of barriers and risks in global medical device market - most notably, maturing industry growth stage, challenging and changing regulatory laws and procedures, and declining profit margins. Hence, in-depth information and enhanced strategic intelligence are needed to minimize the potential risks associated with new entrants into the global medical device industry.
This report focuses on systematic evaluation and analysis of Internal Risks (arising within the industry development itself) and External Risks (arising from the surrounding environments) in global medical devices industry and market. The major internal risks recognized in this industry include industry growth stage, industry competition pressure, market entry barriers, industry volatility, and technology challenge. The major external risks include factors like profit decline, regulation force, effect of foreign direct investment, and other risks (namely shortage of upstream supply, competition from substitutes, and purchase potential decrease).
The risk evaluation and threat rating concentrate on worldwide medical device market under the industry conditions and environments in 2014. Forecasts and projections have been performed for the trend of industry risk over the next six years (2014-2020). All the identified risk factors are measured quantitatively according to our novel numeric system, i.e. each risk is evaluated with our Risk Index Number (RIN) and Risk Intensity Level (RIL). These in-depth appraisals and analysis about risk considerations & controls provide a comprehensive understanding of the current risk factors and likelihood of risk development trends. Moreover, this report also provides wise risk management strategies and concludes Critical Success Factors (CSFs) to help identify fresh growth point and overcome the threats and obstacles of doing manufacture/business in global medical device industry.
Key Topics Covered:
1. Introduction
2. Internal Risk
3. External Risk
4. Summary and Forcast
5. Critical Success Factors (CSFS)
Companies Mentioned
- 3M Co.
- Abbott Laboratories
- Allergan Inc.
- Baxter International Inc.
- Becton, Dickinson and Co.
- Boston Scientific Corp.
- Cardinal Health Inc.
- Covidien plc
- Essilor International SA
- Fresenius Medical Care AG & Co. KGAA
- GE Healthcare
- Johnson & Johnson
- Koninklijke Philips NV
- Medtronic Inc.
- Novartis AG
- Siemens AG
- St. Jude Medical Inc.
- Stryker Corp.
- Terumo Corp.
- Zimmer Holdings Inc.
For more information visit http://www.researchandmarkets.com/research/gfrvn4/investing_in
